These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35917895)

  • 1. VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.
    Jia X; Bai X; Yang X; Wang L; Lu Y; Zhu L; Zhao Y; Cheng W; Shu M; Mei Q; Jin S
    Metabolism; 2022 Oct; 135():155274. PubMed ID: 35917895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A and interleukin -1β facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-κB/caveolin-1/cavin-1 pathway.
    Jia X; Liu Z; Wang Y; Li G; Bai X
    Atherosclerosis; 2023 Jun; 375():87-97. PubMed ID: 36935311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GP73 enhances the ox-LDL-induced inflammatory response in THP-1 derived macrophages via affecting NLRP3 inflammasome signaling.
    Lin YF; Li MH; Huang RH; Zhang SZ; Xu XF; Zhou HM; Liu MH; Liao XX; Liao LZ; Guo Y; Zhuang XD
    Int J Cardiol; 2023 Sep; 387():131109. PubMed ID: 37271284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
    Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
    Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
    Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
    Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
    Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation.
    Peng K; Liu L; Wei D; Lv Y; Wang G; Xiong W; Wang X; Altaf A; Wang L; He D; Wang H; Qu P
    Int J Mol Med; 2015 May; 35(5):1179-88. PubMed ID: 25761252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium.
    Ma P; Zha S; Shen X; Zhao Y; Li L; Yang L; Lei M; Liu W
    Cell Commun Signal; 2019 Aug; 17(1):102. PubMed ID: 31429763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
    Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
    Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE
    Peng Q; Yin R; Zhu X; Jin L; Wang J; Pan X; Ma A
    J Physiol Biochem; 2022 May; 78(2):365-375. PubMed ID: 35079982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-223-3p inhibits oxidized low-density lipoprotein-mediated NLRP3 inflammasome activation via directly targeting NLRP3 and FOXO3.
    Xu W; Qian L; Yuan X; Lu Y
    Clin Hemorheol Microcirc; 2022; 81(3):241-253. PubMed ID: 35275525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
    Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL.
    Song J; Yang S; Yin R; Xiao Q; Ma A; Pan X
    J Cell Biochem; 2019 Aug; 120(8):13640-13650. PubMed ID: 30938884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice.
    Zhao J; Wang Z; Yuan Z; Lv S; Su Q
    Diab Vasc Dis Res; 2020; 17(6):1479164120977441. PubMed ID: 33269624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis.
    Guo S; Wang L; Cao K; Li Z; Song M; Huang S; Li Z; Wang C; Chen P; Wang Y; Dai X; Chen X; Fu X; Feng D; He J; Huo Y; Xu Y
    Cardiovasc Res; 2024 Jul; 120(8):883-898. PubMed ID: 38626254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis.
    Yuan R; Zhang W; Nie P; Lan K; Yang X; Yin A; Xiao Q; Shen Y; Xu K; Wang X; Pan X; Shen L; He B
    Oxid Med Cell Longev; 2022; 2022():2017815. PubMed ID: 35464766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway.
    Zhang H; Gong X; Ni S; Wang Y; Zhu L; Ji N
    Int Immunopharmacol; 2019 Dec; 77():105934. PubMed ID: 31727560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells.
    Bian F; Yang XY; Xu G; Zheng T; Jin S
    Front Pharmacol; 2019; 10():40. PubMed ID: 30761006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
    Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X
    Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.